-
- Wikipedia
ID: SHQQTij1R9
From: en.wikipedia.org
-
A first step vivo gene editing in patients | Medicine
ID: b9xDVZP6tj
From: nature.com
-
Beyond 'superbabies': Crispr is medicine Financial Times
ID: s9f7osG9Dy
From: ft.com
-
CRISPR–Cas9 genome editing p53-mediated DNA damage | Nature Medicine
ID: NlAwUNFEET
From: nature.com
-
kill-switch for CRISPR that could make gene-editing safer
ID: S0DKAQ7MD5
From: nature.com
-
How CRISPR Changing Cancer Research and Treatment National Cancer Institute
ID: T2lPCAVeIV
From: cancer.gov
-
Applications of CRISPR/Cas9 Technology in Treatment of Lung Cancer: Trends Molecular
ID: dRtul1xj9Z
From: cell.com
-
Switch Could Make Gene Editing Safer Scientific American
ID: 341BWhrPES
From: scientificamerican.com
-
Heroes of CRISPR:
ID: 2UKGXNG3xY
From: cell.com
-
The next generation CRISPR–Cas technologies and | Nature Reviews Molecular Cell
ID: Dznwu2Bn2j
From: nature.com
-
Crispr the Next Antibiotic? - The New York Times
ID: ZAsCOBhGYz
From: nytimes.com
-
editing: CRISPR–Cas9 precision genome regulation and interrogation | Nature Reviews Molecular Cell
ID: GGvv0c8Oev
From: nature.com
-
CRISPR Wikipedia
ID: y4GaoObXD2
From: en.wikipedia.org
-
| CRISPR/Cas: From Tumor Gene Editing to Cell-Based Immunotherapy of Cancer | Immunology
ID: O1BnlnFhnD
From: frontiersin.org
-
Controlling and enhancing CRISPR systems | Chemical
ID: yUH5JWEABH
From: nature.com
-
Frontiers | CRISPR Gene Therapy: Applications, Limitations, and for the | Oncology
ID: C6c4c71VaW
From: frontiersin.org
-
New CRISPR genome editing system offers a wide range of versatility in human cells | Broad
ID: uk96uGCcdl
From: broadinstitute.org
-
Nature journal retracts controversial CRISPR paper after admit results may be wrong Retraction
ID: tb6TLlP4qP
From: retractionwatch.com
-
Advancements Obstacles of CRISPR-Cas9 in Translational Research: Molecular Therapy - Methods & Clinical
ID: DJ11iocVBD
From: cell.com
-
Development of CRISPR/Cas9-based therapy for syndrome | Nature Medicine
ID: bIeTFcJb1D
From: nature.com
-
WTF is | TechCrunch
ID: 4R64zEV3E2
From: techcrunch.com
-
CRISPR-Cas9 Gene Editing for Sickle Cell and β-Thalassemia | NEJM
ID: HYpAbzBBA5
From: nejm.org
-
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, and colleagues (featured on p 256 of this month's issue) introduce various combinations mutations associated with human tumors
ID: 8c6JiovtAs
From: zh-cn.facebook.com
-
CRISPR-engineered T in with refractory cancer
ID: NKysGqGvvY
From: science.org
-
in human pluripotent stem cells | Nature Medicine
ID: EnZuYXjH1c
From: nature.com
-
CRISPR Craze to Transform Biology: Trends in Molecular Medicine
ID: wqSvu1kI1M
From: cell.com
-
CRISPR/Cas9: a powerful for of new targets for cancer treatment - ScienceDirect
ID: OD1y2VrzZ8
From: sciencedirect.com
-
The - The York Times
ID: RwhUrQ7DyA
From: nytimes.com
-
Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria | Nature Medicine
ID: 9wB3AyJGM5
From: nature.com